Aurobindo faces US lawsuit over contamination in drug: Reports
Hyderabad-based Aurobindo Pharma is reportedly facing a class action lawsuit in the US over cancer-causing elements in its drug. The drugmaker has been named in the lawsuit for alleged contamination of an Active Pharmaceutical Ingredient (API) used in treatment of high blood pressure, reports added. Shares of the company plunged as much as 6.4% on Thursday following the reports.